A detailed history of Freestone Capital Holdings, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Freestone Capital Holdings, LLC holds 28,886 shares of MRNA stock, worth $758,546. This represents 0.03% of its overall portfolio holdings.

Number of Shares
28,886
Holding current value
$758,546
% of portfolio
0.03%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 13, 2025

BUY
$28.35 - $47.53 $818,918 - $1.37 Million
28,886 New
28,886 $818,000
Q4 2021

Feb 14, 2022

SELL
$225.82 - $368.51 $476,254 - $777,187
-2,109 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$221.9 - $484.47 $467,987 - $1.02 Million
2,109 New
2,109 $315,000
Q1 2021

May 17, 2021

SELL
$109.18 - $185.98 $263,123 - $448,211
-2,410 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$65.74 - $169.86 $148,572 - $383,883
2,260 Added 1506.67%
2,410 $117 Million
Q3 2020

Nov 06, 2020

BUY
$54.34 - $94.85 $8,151 - $14,227
150 New
150 $10,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $10.3B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Freestone Capital Holdings, LLC Portfolio

Follow Freestone Capital Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Freestone Capital Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Freestone Capital Holdings, LLC with notifications on news.